Skip to main
ACHC
ACHC logo

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 36%
Buy 27%
Hold 36%
Sell 0%
Strong Sell 0%

Bulls say

Acadia Healthcare Co., Inc. has demonstrated robust organic growth, highlighted by a 3% year-over-year increase in specialty service admissions, supported by strategic referral source actions at underperforming facilities. The company is poised for continued expansion, with plans for reduced capital expenditures of $300 million year-over-year in 2026, enhancing its cash flow and positioning it well for further acquisitions. Moreover, the ongoing strong demand for behavioral health services, driven by rising community needs, supports a favorable long-term outlook for Acadia Healthcare's revenue growth.

Bears say

Acadia Healthcare Co Inc. is experiencing significant operational challenges, highlighted by a downward revision of its full-year 2025 adjusted EBITDA guidance by $32.5 million, now sitting at $650-660 million. The company faces ongoing headwinds from volume softness and pressure on reimbursement rates, which have negatively impacted its performance, illustrated by a reduction in 2026 adjusted EBITDA estimates to $664.6 million. Additionally, Acadia's capital-intensive growth strategy necessitates sufficient free cash flow or external financing, further compounding the risks associated with profitability amidst fluctuating care costs and the increased burden of bad debt.

Acadia Healthcare (ACHC) has been analyzed by 11 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 27% recommend Buy, 36% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 11 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Nov 26, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $29.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $29.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.